โจทย์ ปรนัย
What is the main advantage of using nanomaterials in electrochemical sensors for medical diagnostics?

The main advantages of using nanomaterials in electrochemical sensors, especially in medical diagnostics, is their ability to enhance the sensor's sensitivity and provide a larger surface area for detecting analytes like biomarkers, DNA, or proteins. This leads to better signal strength, lower detection limits, and faster response time

The integration of nanomaterials such as graphene and CNTs increases the effective surface area and electrical conductivity, thereby enhancing the sensitivity and detection capability of electrochemical sensors. Due to their large surface area and unique properties, nanomaterials can dramatically improve the performance of biosensors, especially in the detection of low-concentration biomarkers

โจทย์ ปรนัย
Which of the following nanomaterials is frequently mentioned as enhancing sensor conductivity?

Among the listed materials, gold nanoparticles are the ones frequently mentioned in the article as enhancing conductivity, sensitivity, and electrochemical performance of sensors

The article highlights that metal nanoparticles, especially gold nanoparticles, play a crucial role in improving the signal transduction capabilities of electrochemical sensors. Their high surface-to-volume ratio and conductivity help in lowering detection limits and improving response time.

โจทย์ ปรนัย
Why are carbon-based nanomaterials such as carbon nanotubes (CNTs) useful in electrochemical sensors?

Carbon-based nanomaterials like carbon nanotubes are widely valued in electrochemical sensors because they enhance electron transfer rates, allowing the sensor to respond more quickly and sensitively to target molecules

Carbon nanotubes provide high electrical conductivity and mechanical stability, making them ideal for improving the performance and durability of electrochemical sensors. Their unique tubluar structure promotes fast electron transfer and a large surface area for biomolecule attachment

โจทย์ ปรนัย
What is one challenge in integrating nanotechnology with electrochemical sensors for medical use?

One of the major challenges mentioned in the article when integrating nanotechnology into electrochemical sensors for medical diagnostics is ensuring reproducibility and standardization. This means producing sensors with consistent performance across different batches and laboratories, which is critical for reliable medical testing and regulatory approval

Despite their promising performance, nanomaterial-based sensors face challenges such as reproducibility, stability, and the lack of standardized fabrication protocols, which hinder their large-scale clinical application

โจทย์ ปรนัย
Which technique is commonly used to enhance the signal in nanotechnology-based electrochemical sensors?

The article highlights magnetic nanoparticles as a common method to enhance signal strength in nanotechnology-based electrochemical sensors. Magnetic nanoparticles enable magnetic separation or pre-concentration of target analytes, which improves the sensitivity by concentrating the biomolecules near the sensor surface and reducing background noise.

Magnetic nanoparticles facilitate target pre-concentration and signal amplification by enabling magnetic separation, which enhances the detection sensitivity of electrochemical sensors

โจทย์ ปรนัย
Why is biocompatibility crucial in designing electrochemical sensors for medical diagnostics?

Biocompatibility is critical in medical diagnostic sensors because these devices often come into direct contact with biological samples, or sometimes even tissues and fluids in wearable or implantable devices. Ensuring biocompatibility helps prevent adverse immune reactions, toxicity, or inflammation, which could harm the patient or interfere with accurate measurements

Nanomaterials used in electrochemical sensors must exhibit high biocompatibility to avoid toxicity and ensure safe interaction with biological samples, especially for wearable or implantable devices

โจทย์ ปรนัย
How do label-free electrochemical sensors differ from labeled ones?

Label-free electrochemical sensors detect target molecules directly by measuring changes in electrical signals without needing extra labels such as flurescent dyes, enzymes, or radioactive tags. This simplifies the sensor design and reduces costs and preparation time

Label-free sensors monitor biomolecular interactions in real time without the need for external labeling, facilitating rapid and cost-effective detection

โจทย์ ปรนัย
What is one promising application of nanotech-based electrochemical sensors?

A key promising application of nanotechnology-based electrochemical sensors in the medical field is the early detection of disease biomarkers. These sensors can detect extremely low concentrations of molecules such as proteins, nucleic acids or small metabolites associated with diseases, enabling early diagnosis and timely treatment

Nanotechology-enhanced electrochemical sensors are especially suited for detecting low-abundance biomarkers, enabling early diagnosis and monitoring of various diseases

โจทย์ ปรนัย
Which of the following factors most directly affects the sensor's detection limit?

The surface-to-volume ratio of nanomaterials is a crucial factor that directly influences the sensor’s detection limit. A higher surface-to-volume ratio provides more active sites for biomolecule interaction, increasing the sensor's sensitivity and allowing it to detect very low concentrations of analytes

Nanomaterials with large surface-to-volume ratios, such as nanoparticles and nanotubes, enhance the active sensing area and lower detection limits by facilitating increased target binding and electron transfer

โจทย์ ปรนัย
What is one of the primary goals of using digital sensing technologies in cancer care?

One of the primary goals of digital sensing technologies in cancer care, as discussed in the article, is to enable earlier detection of cancer and support personalized diagnosis and treatment. These technologies facilitate continuous monitoring and provide real-time data, which helps clinicians tailor therapies to individual patients and intervene sooner

Digital sensing platforms have the potential to transform cancer care by enabling early detection, real-time monitoring, and personalized treatment strategies.

โจทย์ ปรนัย
Which type of sensor is often used to monitor physical activity in cancer patients?

The article explains that accelerometers are commonly used in wearable devices to monitor physical activity in cancer patients. These sensors track movement, steps, and overall activity levels, which are important for assessing patient health, recovery progress, and treatment side effects. Accelerometers help provide objective data to guide rehabilitation and personalized care plans.

Wearable devices equipped with accelerometers enable continuous monitoring of physical activity, which is crucial for managing cancer patient health and tailoring interventions

โจทย์ ปรนัย
Why are patient-reported outcomes important in digital cancer care systems?

Patient report outcomes are vital in digital cancer care because they capture the patient's personal experience, symptoms, and quality of life, which are subjective but crucial data point. These complement the objective data collected by digital sensors giving a fuller picture of the patient’s health status.

Integrating patient-reported outcomes with digital sensor data offers a comprehensive view of patient well-being, supporting holistic cancer care

โจทย์ ปรนัย
What is one major advantage of real-time digital sensing in cancer treatment?

A major advantage of real-time digital sensing technologies in cancer treatment is their ability to quickly detect changes or deterioration in a patient’s condition. This enables timely medical interventions, potentially preventing complications and improving outcomes

Real-time digital sensors facilitate early identification of patient health deterioration, allowing prompt clinical response and improved management of cancer treatment

โจทย์ ปรนัย
Which of the following is a key barrier to implementing digital sensing in routine oncology practice?

The article identifies limited digital literacy—meaning that some patients and healthcare providers may struggle to use or interpret data from digital sensing technologies—as a significant barrier to widespread adoption in oncology care. This challenge can hinder effective use, data interpretation, and trust in these advanced tools, impacting their integration into routine clinical practice.

Barriers such as limited digital literacy among both patients and clinicians slow the integration of digital sensing technologies into standard oncology workflow

โจทย์ ปรนัย
Which stakeholders are considered central to the adoption of digital cancer care platforms?

The article emphasizes that patients and healthcare providers are the central stakeholders in adopting digital cancer care platforms. Their engagement, acceptance, and ability to use these technologies effectively determine the success of implementation. Patients provide critical feedback and data through sensors and apps, while healthcare providers interpret this data to guide treatment. Collaboration between these groups is essential

Successful adoption of digital sensing in cancer care hinges on active participation from patients and clinicians, who serve as the primary users and decision-makers

โจทย์ ปรนัย
Digital sensing systems collect which combination of data types for cancer care optimization?

Digital sensing systems in cancer care optimize treatment by combining objective sensor data with subjective patient-reported outcomes, such as symptoms and quality of life reports. This comprehensive data integration enables personalized, holistic care

Integration of sensor-derived metrics with patient-reported outcomes provides a multidimensional understanding of patient health, crucial for optimizing cancer care

โจทย์ ปรนัย
How do digital sensors contribute to improving the quality of life in cancer patients?

Digital sensors help improve the quality of life for cancer patients by allowing continuous tracking of symptoms and health indicators, which facilitates early detection of complications or adverse effects. This enables timely medical interventions, better symptom management, and personalized care plans that can reduce hospital visits and improve overall well-being

Continuous monitoring through digital sensors enables proactive management of symptoms, helping patients maintain a better quality of life throughout their cancer journey

โจทย์ ปรนัย
What does the article suggest about the future direction of digital sensing in cancer care?

The article emphasizes that digital sensing technologies are advancing toward enabling personalized, real-time, and patient-centered cancer care. These tools are expected to play a growing role in tailoring treatments to individual patients' needs by integrating continuous sensor data with other digital health records.

Digital sensing technologies are positioned to enable the delivery of personalized cancer care at scale, by integrating real-time data into clinical decision-making

โจทย์ ปรนัย
Based on the diagram, which of the following would most likely result in a false signal output in an electrochemical sensor for medical diagnostics?

Electrochemical biosensors rely on a carefully optimized interface between the biorecognition element and the transducer. Overloading the sensor with too many bioreceptors, especially without proper sample optimization, can lead to nom-specific binding or steric hindrance, which can distort the electrochemical signals and lead to false positives or negatives

The stability and sensitivity of electrochemical biosensors depend significantly on the uniform immobilization of the recognition element. Overloading the surface without optimizing the conditions may hinder the target interaction or produce noise, leading to false signal outputs

โจทย์ ปรนัย
Based on the image, which of the following scenarios best demonstrates the advantage of using emerging digital platforms in cancer diagnostics?

Digital sensing platforms (like portable chip-based biosensors) enable rapid, real-time, and non-invasive detection of cancer biomarkers

Portable biosensors using electrochemical or optical detection modalities are increasingly capable of identifying cancer biomarkers in body fluids within mintues, enabling point-of-care diagnosis